Program Chair’s Conclusions, Take-Home Messages and Summary Focus on the Evolving, Evidence-Based Role of SSAs and Other Novel Therapies for Prolongation of Progression-Free Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors - Michael A. Morse, MD - Program Chair